久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA lifts clinical hold from Mersana’s breast cancer trial fiercebiotech
    September 18, 2018
    The FDA has?lifted?the partial clinical hold it placed on a phase 1 trial of Mersana Therapeutics’ HER2-targeted antibody-drug conjugate (ADC). Regulatory officials put enrollment in the XMT-1522?breast cancer trial on hold in July after learning of the d

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service